Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0684
D

Failure to Implement Care Plan and Monitoring for Anticoagulant Therapy

Las Vegas, Nevada Survey Completed on 05-09-2025

Penalty

Fine: $8,278
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

A deficiency occurred when the facility failed to formulate a care plan for anticoagulant use and did not obtain a physician order for monitoring a resident receiving anticoagulant therapy. The resident, who had diagnoses including dementia, Parkinson's disease, and gait abnormalities, was admitted and prescribed Lovenox for deep vein thrombosis. Although the medication was administered as ordered, there was no documented evidence of a care plan addressing anticoagulant use, nor was there a physician order in place for monitoring the resident for potential bleeding or adverse reactions during the course of therapy. Staff interviews confirmed that routine assessments for signs of bleeding, such as bruising, bleeding gums, hematuria, and black tarry stools, were not conducted or documented prior to or during the administration of Lovenox. The lack of a monitoring order meant that no prompts were generated for staff to implement necessary assessments, and the Medication Administration Record did not reflect any monitoring for bleeding or coagulation issues. The facility's own policy required such monitoring and documentation, but these steps were not followed for this resident.

An unhandled error has occurred. Reload 🗙